Table 3.
UOR, AOR, and 95% CI
| COVID-19 Outcome | ||
|---|---|---|
| UOR (95% CI) | AOR (95% CI) | |
| Vitamin D (25OH), ng/mLa | 0.43 (0.22–0.82) | 0.29 (0.11–0.67) |
| MGP (dp-ucMGP), ng/mLb | 2.07 (1.29–3.48) | 1.84 (1.01–3.45) |
| C-reactive protein, mg/dLb | 1.83 (1.47–2.34) | 1.83 (1.42–2.43) |
| Age, ya | 1.02 (0.99–1.04) | 0.72 (0.27–2.48) |
| Female | 0.84 (0.40–1.78) | 0.56 (0.22–1.40) |
| Non-White | 0.61 (0.27–1.35) | 0.76 (0.23–2.47) |
| Comorbidities (any) | 1.35 (0.58–3.18) | 0.79 (0.23–2.82) |
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; AOR, adjusted odds ratio; COVID-19, coronavirus disease 3019; dp-ucMGP, dephosphorylated uncarboxylated matrix Gla protein; UOR, unadjusted odds ratio.
aNatural log transformed.
bLog(base)2 transformed.